title: Campath-1H in intestinal and multivisceral transplantation: preliminary data.
authors.affiliation: Department of Surgery, University of Miami School of Medicine, Miami, FL 33136, USA.
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Nishida
authors.forename: D
authors.initials: D
authors.lastname: Levi
authors.forename: J
authors.initials: J
authors.lastname: Madariaga
authors.forename: W
authors.initials: W
authors.lastname: De Faria
authors.forename: J
authors.initials: J
authors.lastname: Nery
authors.forename: G
authors.initials: G
authors.lastname: Neff
authors.forename: A D
authors.initials: AD
authors.lastname: Kirk
authors.forename: P
authors.initials: P
authors.lastname: Ruiz
mesh_terms: D000328:Adult; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007422:Intestines / Q000637:transplantation*; D007902:Length of Stay; D007958:Leukocyte Count; D016031:Liver Transplantation / Q000276:immunology; D018655:Lymphocyte Count; D010289:Parenteral Nutrition, Total; D011184:Postoperative Period; D012086:Reoperation; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000276:immunology*; D014781:Viscera / Q000637:transplantation*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D016559:Tacrolimus